Logo-ps

 

 

 

Follower of ICMJE

Powered by:
Pharm Sci. 2021;27(3): 418-432. doi: 10.34172/PS.2020.96

Research Article

Efavirenz Loaded Nanostructured Lipid Carriers for Efficient and Prolonged Viral Inhibition in HIV-Infected Macrophages

Ketan Mahajan 1 ORCID, Satish Rojekar 1, Dipen Desai 2, Smita Kulkarni 2 ORCID, Pradeep Vavia 1 * ORCID

Cited by CrossRef: 7

1- Faria M, Lopes C, das Neves J, Lúcio M. Lipid Nanocarriers for Anti-HIV Therapeutics: A Focus on Physicochemical Properties and Biotechnological Advances. Pharmaceutics. 2021;13(8):1294 [Crossref]
2- Rojekar S, Pai R, Abadi L, Mahajan K, Prajapati M, Kulkarni S, Vavia P. Dual loaded nanostructured lipid carrier of nano-selenium and Etravirine as a potential anti-HIV therapy. International Journal of Pharmaceutics. 2021;607:120986 [Crossref]
3- Fotooh Abadi L, Damiri F, Zehravi M, Joshi R, Pai R, Berrada M, Massoud E, Rahman M, Rojekar S, Cavalu S. Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs. Polymers. 2022;14(15):3090 [Crossref]
4- Vitore J, Pagar S, Singh N, Karunakaran B, Salve S, Hatvate N, Rojekar S, Benival D. A comprehensive review of nanosuspension loaded microneedles: fabrication methods, applications, and recent developments. J Pharm Investig. 2023;53(4):475 [Crossref]
5- Suriyarachchi D, Katuwavila N. Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment. HIV Medicine. 2025; [Crossref]
6- Jain P, Parikh S, Patel P, Shah S, Patel K. Comprehensive insights into herbal P-glycoprotein inhibitors and nanoformulations for improving anti-retroviral therapy efficacy. Journal of Drug Targeting. 2024;32(8):884 [Crossref]

   Indexing & Abstracting: